Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice.
Zapata-Pérez R, Tammaro A, Schomakers BV, Scantlebery AML, Denis S, Elfrink HL, Giroud-Gerbetant J, Cantó C, López-Leonardo C, McIntyre RL, van Weeghel M, Sánchez-Ferrer Á, Houtkooper RH.
Zapata-Pérez R, et al.
FASEB J. 2021 Apr;35(4):e21456. doi: 10.1096/fj.202001826R.
FASEB J. 2021.
PMID: 33724555